福元医药
(601089)
| 流通市值：95.90亿 | | | 总市值：95.90亿 |
| 流通股本：4.80亿 | | | 总股本：4.80亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 811,169,644.86 | 3,504,445,642.69 | 2,520,605,126.57 | 1,633,971,250.02 |
| 营业收入 | 811,169,644.86 | 3,504,445,642.69 | 2,520,605,126.57 | 1,633,971,250.02 |
| 二、营业总成本 | 719,694,446.91 | 2,991,036,068.12 | 2,120,432,691.61 | 1,345,375,722.9 |
| 营业成本 | 310,714,712.85 | 1,208,580,165.12 | 858,150,245.81 | 547,546,114.03 |
| 税金及附加 | 9,284,226.49 | 40,870,457.35 | 28,149,405.85 | 18,678,286.14 |
| 销售费用 | 265,104,034.32 | 1,199,310,097.23 | 852,042,091.19 | 548,468,828.83 |
| 管理费用 | 36,664,115.39 | 150,598,562.85 | 109,700,862.91 | 69,310,070.02 |
| 研发费用 | 97,858,133.46 | 403,415,656.85 | 276,839,281.61 | 165,691,773.89 |
| 财务费用 | 69,224.4 | -11,738,871.28 | -4,449,195.76 | -4,319,350.01 |
| 其中:利息费用 | 246,710.85 | 1,579,732.14 | 1,269,503.11 | 939,165.49 |
| 其中:利息收入 | 455,537.43 | 13,576,613.3 | 5,809,443.96 | 5,250,418.46 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 5,171,913.77 | 17,607,903.8 | 15,559,343.77 | 12,989,935.7 |
| 资产处置收益 | 420,001.28 | 21,837.92 | 217,888.5 | -35,004.55 |
| 资产减值损失(新) | -2,196,736.24 | -16,491,237.75 | -5,395,963.39 | -4,085,112.27 |
| 信用减值损失(新) | 1,760,515.09 | -2,879,787.91 | -1,058,878.15 | -566,309.52 |
| 其他收益 | 7,275,477.41 | 21,985,777.59 | 13,153,417.64 | 8,797,559.28 |
| 四、营业利润 | 103,906,369.26 | 533,654,068.22 | 422,648,243.33 | 305,696,595.76 |
| 加:营业外收入 | 468,028.52 | 1,149,796.21 | 909,160.47 | 731,479.2 |
| 减:营业外支出 | 317,591.5 | 11,459,499.08 | 5,693,975.46 | 4,910,008.82 |
| 五、利润总额 | 104,056,806.28 | 523,344,365.35 | 417,863,428.34 | 301,518,066.14 |
| 减:所得税费用 | 7,859,331.14 | 52,080,830.35 | 40,073,476.09 | 33,045,980.6 |
| 六、净利润 | 96,197,475.14 | 471,263,535 | 377,789,952.25 | 268,472,085.54 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 96,197,475.14 | 471,263,535 | 377,789,952.25 | 268,472,085.54 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 95,411,871.24 | 469,364,240.73 | 375,340,383.05 | 267,867,639.64 |
| 少数股东损益 | 785,603.9 | 1,899,294.27 | 2,449,569.2 | 604,445.9 |
| 扣除非经常损益后的净利润 | 89,500,072.61 | 450,867,655.34 | 361,821,020.81 | 258,234,147.69 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.2 | 1 | 0.78 | 0.56 |
| (二)稀释每股收益 | 0.2 | 1 | 0.78 | 0.56 |
| 九、综合收益总额 | 96,197,475.14 | 471,263,535 | 377,789,952.25 | 268,472,085.54 |
| 归属于母公司股东的综合收益总额 | 95,411,871.24 | 469,364,240.73 | 375,340,383.05 | 267,867,639.64 |
| 归属于少数股东的综合收益总额 | 785,603.9 | 1,899,294.27 | 2,449,569.2 | 604,445.9 |
| 公告日期 | 2026-04-25 | 2026-04-14 | 2025-10-30 | 2025-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |